147 related articles for article (PubMed ID: 30410369)
1. Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.
Zhang DY; Liu Z; Lu Z; Sun WL; Ma X; Zhang P; Wu BQ; Cui PY
Onco Targets Ther; 2018; 11():7133-7142. PubMed ID: 30410369
[TBL] [Abstract][Full Text] [Related]
2. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas.
Ruokun C; Yake X; Fengdong Y; Xinting W; Laijun S; Xianzhi L
Tumour Biol; 2016 Nov; 37(11):15065-15077. PubMed ID: 27658777
[TBL] [Abstract][Full Text] [Related]
4. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
5. [HSDL2 overexpression promotes rectal cancer progression by regulating cancer cell cycle and promoting cell proliferation].
Cheng Y; He X; Wang L; Xu Y; Shen M; Zhang W; Xia Y; Zhang J; Zhang M; Wang Y; Hu J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):544-551. PubMed ID: 37202189
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated
Zeng J; Ma X; Wang J; Liu R; Shao Y; Hou Y; Li Z; Fang Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31101684
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer.
Dong B; Yang Y; Han A; Zhang S; Lin Z; Wang Y; Piao J
Cancer Manag Res; 2019; 11():6531-6542. PubMed ID: 31372054
[TBL] [Abstract][Full Text] [Related]
9. Role of Hydroxysteroid Dehydrogenase-Like 2 (HSDL2) in Human Ovarian Cancer.
Sun Q; Zhang Y; Su J; Li T; Jiang Y
Med Sci Monit; 2018 Jun; 24():3997-4008. PubMed ID: 29894468
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression.
Liu WB; Wang HL; Chen L; Tang B; Ke G; Wang S; Sun YQ; Ma J; Lyu DL
Chin Med; 2022 Feb; 17(1):28. PubMed ID: 35193614
[TBL] [Abstract][Full Text] [Related]
11. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
[TBL] [Abstract][Full Text] [Related]
13. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
15. miR-365 Suppresses Cholangiocarcinoma Cell Proliferation and Induces Apoptosis by Targeting E2F2.
Chen L; Huang X; Chen X
Oncol Res; 2018 Oct; 26(9):1375-1382. PubMed ID: 29471889
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
17. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
18. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
Zhou Z; Ma J
Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
[TBL] [Abstract][Full Text] [Related]
19. HSDL2 Acts as a Promoter in Pancreatic Cancer by Regulating Cell Proliferation and Lipid Metabolism.
Han A; Xu R; Liu Y; Yin X; Lin Z; Yang W
Onco Targets Ther; 2021; 14():435-444. PubMed ID: 33488098
[TBL] [Abstract][Full Text] [Related]
20. mir-637 inhibits the proliferation of cholangiocarcinoma cell QBC939 through interfering CTSB expression.
Li JX; Ding XM; Han S; Wang K; Jiao CY; Li XC
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1265-1276. PubMed ID: 29565483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
